Lisa Schulmeister, RN, MN, APRN-BC, OCN®, FAAN Editor-in-Chief OncLive Nursing Oncology Nursing Consultant, Adjunct Assistant Professor of Nursing Louisiana State Health Sc...
Susan J. Keen, RN, OCN Deborah L. Selm-Orr, RN, MS, CRNP, AOCN What is the value of maintenance therapy in patients with lung or breast cancers, and how and when should it be used? ...
Colleen Jennings, RN, BSN, HN-BC, of Cancer Treatment Centers of America at Eastern Regional Medical Center, discusses the initiative their center took to improve discharge follow-up calls. The ...
Rebecca Kronk, PhD, CRNP, MSN Assistant Professor, Duquesne University School of Nursing Over the past decade, evidence has mounted recognizing sleep disturbances an...
Amy Zhang, PhD A new study has found that African American patients with cancer feel and describe depression differently than their Caucasian counterparts. Findings from a pilot study, pos...
Cancer and its treatments can bring a number of adverse events (AEs), and as more patients are living longer after their treatment, these effects can become long-lasting. Often, oncology nurses are...
The FDA has approved crizotinib (Xalkori) for the treatment of pediatric patients 1 year of age and older and young adults with ALK-positive relapsed or refractory, systemic anaplastic large c...
Molecular testing is a critical component of the treatment selection process in lung cancer, as a host of effective drugs have since been developed to target alterations such as ALK, ROS1...